Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients

(2010) Andrew S. Kennedy et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set

(2010) David S. Klimstra et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)

(2010) R. Garcia-Carbonero et al.   ANNALS OF ONCOLOGY

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

(2010) N C Turner et al.   BRITISH JOURNAL OF CANCER

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

(2010) David L. Bushnell et al.   JOURNAL OF CLINICAL ONCOLOGY

Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients

(2010) Aldo Scarpa et al.   MODERN PATHOLOGY

The Pathologic Classification of Neuroendocrine Tumors

(2010) David S. Klimstra et al.   PANCREAS

Targeted hyperthermia using metal nanoparticles

(2009) Paul Cherukuri et al.   ADVANCED DRUG DELIVERY REVIEWS

Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine Tumors

(2009) Karl Y. Bilimoria et al.   ANNALS OF SURGERY

Molecular target therapy for gastroenteropancreatic endocrine tumours: Biological rationale and clinical perspectives

(2009) Gabriele Capurso et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Neuroendocrine tumors of the diffuse neuroendocrine system

(2009) Björn I Gustafsson et al.   CURRENT OPINION IN ONCOLOGY

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

(2009) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor

(2009) Oliver Stoeltzing et al.   LANGENBECKS ARCHIVES OF SURGERY

Endocrine Pancreatic Tumors in von Hippel-Lindau Disease

(2009) Olivier Corcos et al.   PANCREAS

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases

(2008) Julie King et al.   CANCER

Molecular genetics of gastroenteropancreatic neuroendocrine tumors

(2008) Lee F Starker et al.   CURRENT OPINION IN ONCOLOGY

Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis

(2008) E.-M. Duerr et al.   ENDOCRINE-RELATED CANCER

Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation

(2008) Thomas J. Vogl et al.   EUROPEAN JOURNAL OF RADIOLOGY

Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

(2008) Matthew H. Kulke et al.   JOURNAL OF CLINICAL ONCOLOGY

Yttrium-90 Microsphere Radioembolotherapy of Hepatic Metastatic Neuroendocrine Carcinomas after Hepatic Arterial Embolization

(2008) Ravi Murthy et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY

Disruption of Tsc2 in pancreatic   cells induces   cell mass expansion and improved glucose tolerance in a TORC1-dependent manner

(2008) L. Rachdi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy

(2008) Dara Christante et al.   SURGERY

Liver transplantation for primary and metastatic liver cancers

(2008) Emir Hoti et al.   TRANSPLANT INTERNATIONAL

Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver

(2008) Avo Artinyan et al.   HPB